AI assistant
Sending…
Cellectar Biosciences, Inc. — Director's Dealing 2014
Dec 18, 2014
35021_dirs_2014-12-18_c1a8d034-316a-4979-90c7-002793e21a85.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2014-11-24
Reporting Person: Szakacs Cameron (VP of Clinical Development)
More from Cellectar Biosciences, Inc.
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Mar 4
Annual Report
2026
Mar 4
Major Shareholding Notification
2026
Feb 10
Major Shareholding Notification
2026
Feb 4